Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
ARVN | ARVINAS, INC. | Chief Financial Officer | $4.4M | Jun 24, 2024 | ||
VYNE | VYNE Therapeutics Inc. | Chief Financial Officer | $266K | May 28, 2021 | ||
ICPT | INTERCEPT PHARMACEUTICALS, INC. | EVP & Chief Financial Officer | Nov 8, 2023 | |||
MIST | Milestone Pharmaceuticals Inc. | Director | Aug 28, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|